Skip to main content
. 2022 Sep 2;25:430–444. doi: 10.1016/j.bioactmat.2022.08.010

Fig. 7.

Fig. 7

Stimulus-responsive nanocarriers for human diseases including solid tumours, cardiovascular diseases (e.g. atherosclerotic peripheral arterial disease (PAD)), single-gene diseases (e.g. biallelic RPE65-associated retinal dystrophy (BRARD)), and idiopathic diseases (e.g. Crohn's disease and idiopathic pulmonary fibrosis) Reproduced with permission [118]. Copyright 2021. Wiley-VCH.